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ABSTRACT  
Objective: To identify risk factors for lower quality of life (QOL) in non-metastatic breast 
cancer patients. 
Methods: Our study included 120 patients from the University Hospital Centers of Tours and 
Poitiers. This cross-sectional study was conducted 7 months after patients’ breast cancer 
diagnosis and assessed QOL (Quality of Life Questionnaire-Core 30 = QLQ-C30), socio-
demographic characteristics, coping strategies (Brief-Cope), physiological and biological 
variables (e.g., initial tumor severity, types of treatment received), the existence of major 
depressive disorder (Mini International Neuropsychiatric Interview) and pain severity 
(QDSA). We assessed personality disorders 3 months after diagnosis (VKP questionnaire). 
We used multiple linear regression models to determine which factors were associated with 
physical, emotional and global QOL.  
Results: Lower physical QOL was associated with major depressive disorder, younger age, a 
more severe initial tumor stage and the use of the behavioral disengagement coping. Lower 
emotional QOL was associated with major depressive disorder, the existence of a personality 
disorder, a more severe pain level, higher use of self-blame and lower use of acceptance 
coping strategies. Lower global QOL was associated with major depressive disorder, the 
existence of a personality disorder, a more severe pain level, higher use of self-blame and 
lower use of positive reframing coping strategies and an absence of hormone therapy. 
Conclusions: Lower QOL scores were more strongly associated to variables related to the 
individual’s premorbid psychological characteristics and the manner in which this individual 
copes with the cancer (e.g., depression, personality and coping) than to cancer-related 
variables (e.g., treatment types, cancer severity).  
Key words: cancer, oncology, quality of life, coping, depression.  
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INTRODUCTION 
Breast cancer has become a major public health issue because it is the most common cancer that 
affects women in terms of both prevalence and incidence [1]. Thanks to better screening and advances 
in treatment since the 1980s, there has been a significant reduction in the mortality rate from breast 
cancer [2], allowing clinicians to focus on improvements in quality of life (QOL) and psychological 
well-being, rather than solely on life expectancy, in this patient population [3]. The concept of QOL, 
which refers to the subjective assessment of a patient’s health, has become a major outcome measure 
in medicine (along with mortality and morbidity) because it assesses a patient’s subjective view of 
his/her health and serves as a prognostic factor [4].  
Following a diagnosis of breast cancer, an assessment of QOL is an important clinical 
outcome measure because patients have to face major stressors that are likely to deteriorate their QOL, 
not only just after diagnosis but also in the long term (e.g., facing a life-threatening illness, painful and 
impairing treatments, significant role changes, and issues pertaining to body image) [5,6]. To design 
early therapeutic interventions that can improve QOL in this population, a better understanding is 
needed regarding which factors are associated with QOL.  
Several types of factors are considered to be QOL risk factors in non metastatic breast cancer 
patients, such as individual variables (e.g., younger age, less frequent use of active coping, religious 
coping and acceptance, personality traits such as high neuroticism) [7–11], and measures of symptoms 
(e.g., higher pain, higher anxiety and higher depression) [11,15,16]. Other studies that focused on 
biological and physiological variables found mixed results: some authors found that alteration in 
physical, emotional and social QOL was not associated with tumor severity nor treatment type [12,13], 
while some others found an association with use of chemotherapy or radiotherapy [14,15]. These 
studies also demonstrated that QOL could differ depending on the duration of illness [7,8]. Finally, 
social support (that encompasses tangible support, emotional informational support, affectionate 
support and positive social interaction) was associated with higher QOL and acted as a moderator 
between depressive symptoms and QOL [17]. 
Although many studies independently assessed the potential impact of each of these variables, 
no study assessed the relative impact of these variables on QOL in an integrative model. To our 
knowledge, no studies assessed whether QOL was more strongly associated with biological variables 
(i.e., disease severity, treatments) or with variables related to the individual’s characteristics prior to 
the disease and to the manner in which this individual copes with the disease (i.e., measures of 
symptoms such as depression; individual variables such as coping and personality). In addition, we do 
not know yet whether depression, personality and coping strategies are three independent risk factors 
for lower QOL or if their association with QOL is due to other potential confounding variables. 
Finally, no studies assessed depression and personality using a categorical approach (i.e., major 
depressive disorder and personality disorder). 
To improve our knowledge of the factors that are associated with QOL in multivariate 
analyses, we proposed and tested a working model that aimed to assess the relative impact of 
biological and physiological variables (i.e., tumor severity, types of treatment used), individual 
variables (i.e., age, coping, personality, marital status), and measures of symptoms (i.e., depression, 
pain) on QOL. This modified model was based on Wilson & Cleary’s QOL theoretical model [18], 
which is one of the most commonly used and referenced models in the health-related QOL literature 
[19]. 
This study aimed to determine which factors were associated with physical, emotional and 
global QOL in non-metastatic breast cancer patients at the end of their initial treatment phase (7 
months after diagnosis). We hypothesized that, even after adjusting for the severity of disease and 
types of treatment that were received, major depressive disorder, personality disorders and certain 
coping strategies (i.e., more frequent use of avoidant coping strategies and less frequent use of active 
coping strategies) were significant and independent risk factors for lower QOL. 
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MATERIAL AND METHODS 
Participants and procedure 
The participants in this study were recruited based on protocols from the ESPOIR study (Early 
Screening for Psycho-Oncological Intervention Research) that aimed to identify early psychological 
risk factors for psychiatric disorders in breast cancer patients at the end of their treatment phase (7 
months post diagnosis). Participants were recruited between May 2006 and November 2007 from the 
Gynecology Department of the Tours and Poitiers University Hospitals, located in France.  
 Patients were considered eligible for the study if they were being diagnosed with breast cancer 
for the first time and if no metastasis was detected during their diagnosis. They were also required to 
understand French. Patients were excluded if they had metastasis, presented with a relapse of breast 
cancer, had a cancer of another organ in the past, had difficulties with understanding the study or the 
assessment instruments, or simply refused to participate. The data collection was conducted 7 months 
after cancer diagnosis by experienced psychologists (except for personality disorders which were 
assessed 3 months after cancer diagnosis). 141 out of 233 potentially eligible patients participated 
(response rate=60.5%). 
Measured variables  
Individual characteristics (age, personality, coping and marital status) 
We assessed the following variables in each patient: age, occupational and marital status (i.e., single or 
in a relationship).  
 Personality disorders were assessed using the French version of the VKP questionnaire 
(Vragenlijst voor Kenmerken van de Persoonlijkheid) [20]. The VKP is a 197-item, self-administered 
questionnaire based on the International Personality Disorder Examination (IPDE) and evaluates the 
presence of each of the 10 personality disorders according to the ICD-10 and DSM-IV diagnostic 
criteria [21]. 
We assessed coping strategies using the French version of the Brief-COPE scale [22], which is 
a short version of the COPE inventory [23]. The Brief-COPE assesses 14 coping strategies (two items 
per coping): active coping, planning, use of instrumental support, use of emotional support, venting, 
behavioral disengagement, self-distraction, self-blame, positive reframing, humor, denial, acceptance, 
religion and substance use; a higher score indicating a more frequent occurrence of the particular 
coping strategy.  
Biological and physiological variables (severity of disease, types of treatment received) 
The severity of breast cancer was assessed in each patient using the international Tumor Node 
Metastasis (TNM) staging system (T0, T1, T2, T3 or T4; N0 or N1) and the detection of hormonal 
receptors. We also assessed medical data that was related to patient care, including the existence of 
chemotherapy, tumor excision surgery and/or mastectomy, axillary lymph node dissection, 
radiotherapy and/or hormone therapy. 
Symptom measures: major depressive disorder and pain 
We evaluated the presence of major depressive disorder using the Mini International Neuropsychiatric 
Interview (MINI) version 5.0.0. The MINI is a semi-structured interview that assesses psychiatric 
disorders according to the DSM-IV diagnostic criteria. The MINI has been validated by Sheehan et al. 
[24] and was translated into the French language and validated by Lecrubier et al [25]. The MINI is a 
reliable and valid instrument to assess major depressive disorder (sensitivity=96%, specificity=88% 
and kappa coefficient =0.84 [24,25]). 
 To assess pain, we utilized the Questionnaire de Douleur Saint Antoine (QDSA) [26], which is 
an adaptation and French language translation of the McGill Pain Questionnaire [27]. The QDSA is a 
verbal, multidimensional, self-administered scale that assesses sensorial and affective aspects of pain; 
higher score indicate a higher pain level. The QDSA has been validated in oncology settings [26]. 
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Assessment of QOL 
We assessed QOL using the French version of the Quality of Life Questionnaire-Core 30 (QLQ-C30) 
questionnaire [28], which is an international 30-items questionnaire designed by the European 
Organization for the Research and Treatment of Cancer (EORTC) to assess cancer-specific QOL [29] 
and that compose a global QOL scale and five functional scales (i.e., physical, emotional, social, 
cognitive functioning and ability to work) [29]. Each scale is scored from 0 to 100; higher scores 
indicate better QOL. In this study, we focused on physical, emotional and global QOL because they 
are the most frequently studied QLQ-C30 dimensions.  
Ethical considerations  
This study was approved by the ethics committee of the University Hospital Center of Tours, France. 
All procedures have been performed in accordance with the ethical standards described in the 1964 
Declaration of Helsinki. All participants provided written informed consent prior to their inclusion in 
the study.  
Statistical analysis 
The R statistical software package version 2.15.2 (R Development Core Team, Vienna, Austria), was 
used to perform the data analysis of this study [30].  
To determine which factors were associated with each QOL dimension (i.e., physical, 
emotional and global QOL), we used a two-stage approach. First, we used univariate analyses 
(correlation tests and mean comparisons) to determine which variables were significantly associated 
with each QOL dimension. Second, we used multivariate analyses (multiple linear regression) to 
determine which variables were associated with each QOL dimension, after adjusting for potential 
confounding factors: age, initial tumor stage, use of hormone therapy, pain, presence of major 
depressive disorder and use of coping strategies. We verified that the basic assumptions for multiple 
linear regression were met for all of our analyses, especially for the normality of residuals. For each 
dependent variable, we specified the beta regression coefficient, its standard deviation and the 
associated t- and p-values. Statistical significance was considered when the p-value ≤ 0.05. 
 
 
RESULTS 
Population  
A total of 141 patients were initially enrolled in our study shortly after diagnosis. Sixteen of these 141 
patients were withdrawn from the study due to metastatic evolution (3 patients), withdrawal of consent 
(6 patients), or loss to follow-up (7 patients). The eligible patient population at the end of the treatment 
phase consisted of 125 patients; however, 5 participants had missing data from at least one 
questionnaire. Therefore, our final study population included 120 patients. 
Sample characteristics 
Table 1 shows the individual (e.g., age, occupational and marital status, personality, coping), and the 
biological and physiological variables (e.g., tumor characteristics, types of treatment received) of our 
population. Mean QOL scores were 83.7±13.4 for physical QOL, 78.5±23.3 for emotional QOL and 
66.7±18.8 for global QOL. 
Factors associated with physical, emotional and global QOL 
Univariate analyses 
Factors that were associated with each QOL dimension are presented in Table 2. 
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Multivariate analyses (Table 3) 
Physical QOL was significantly lower in patients who had a more severe initial tumor stage or major 
depressive disorder, and in patients who used the behavioral disengagement coping strategy more 
frequently, but it was not associated with pain, existence of a personality disorder or hormone therapy. 
These factors explained 13.5% of the total variation in physical QOL. 
Emotional QOL was significantly lower in patients who had higher pain levels, major 
depressive disorder, or a personality disorder, and in patients who used the self-blame coping strategy 
more frequently or the acceptance coping strategy less frequently, but it was not associated with age, 
initial tumor stage or hormone therapy. These factors explained 48.7% of the total variation in 
emotional QOL. 
Global QOL was significantly lower in patients who had major depressive disorder, in patients 
who were not prescribed hormone therapy, in patients who used the self-blame coping strategy more 
frequently, and in patients who used the positive reframing coping strategy less frequently, but it was 
not associated with age, initial tumor stage, pain level or existence of a personality disorder. These 
factors explained 26% of the total variation in global QOL. 
 
DISCUSSION 
In this study, which was conducted in non-metastatic breast cancer patients at the end of their initial 
treatment phase (7 months after diagnosis), we found that QOL was associated much more to 
measures of symptoms (i.e., depression) and individual characteristics (i.e., age, personality, coping) 
than to biological variables (i.e., tumor severity and types of treatment received). We also found that 
even after adjustment for potential confounding factors, major depressive disorder, personality 
disorders and coping were three independent and important risk factors for lower QOL. 
First, we demonstrated that QOL was more strongly associated to variables related to the 
individual’s characteristics prior to the disease (i.e., age, personality) and to the manner in which this 
individual copes with the disease (i.e., coping, depression and pain) than to biological or physiological 
variables related to the severity of the cancer or to its treatment. Our results support the hypothesis that 
in non-metastatic breast cancer patients, the diagnosis of breast cancer (rather than the severity of this 
cancer) could reveal specific risk factors for lower QOL, including younger age (i.e., younger patients 
might experience higher personal and social distress due to their altered body image) [31], higher pain 
(i.e., these patients might be more susceptible to the fear of cancer recurrence and thus experience 
lower emotional QOL; higher pain could also be due to higher depression), existence of a 
psychological vulnerability prior to the diagnosis (i.e., patients with a personality disorder or with 
depression), and use of some coping strategies after diagnosis. Higher tumor severity could be a less 
important risk factor associated only with lower physical, but not with emotional nor global QOL 
[7,8,12,13]. In addition, the subjective impact of the treatment rather than the types of treatment used 
might be risk factors for lower QOL. 
Our second main result was that depression, personality disorders and coping were three 
independent risk factors for lower QOL. The fact that major depressive disorder was the variable 
associated with the strongest decrease in QOL on all three dimensions (decrease of 38.2 points on 
emotional QOL, 24.2 points on global QOL and 10.6 points on physical QOL) is in line with previous 
studies [15,32,33]. Depression can have a direct (e.g., via a systematic cognitive bias regarding the 
treatment of information that leads to a negative self-assessment of health) or indirect (e.g., via a 
greater difficulty with acquiring new coping strategies that improve QOL) impact on QOL [34].  
Existence of a personality disorder was another independent risk factor, but only for lower 
emotional QOL. To explain the previously demonstrated associations between personality dimensions 
(i.e., trait anxiety and neuroticism) and physical, emotional and global QOL [9,11], we can assume 
that the deterioration in global and physical QOL could be due to confounding factors (e.g., 
depression) while the deterioration in emotional QOL could be directly due to the personality disorder. 
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These results suggest that when a patient with a personality disorder reports low physical or global 
QOL, the personality disorder cannot explain this low QOL and it is important to screen for and treat 
other risk factors. 
Interestingly, the coping strategies associated with lower QOL (i.e., low positive reframing, 
low acceptance, high self-blame and high behavioural disengagement) were mainly avoidant coping 
strategies (i.e., coping strategies that lead individuals to activities or mental states that prevent them 
from directly addressing stressful events) [35]. Although these strategies may be effective in the short 
term, if the stressor is uncontrollable, it may lead to lower psychological adjustment in the long term 
[35]. These strategies may also indicate patients who attempt to avoid the experience of grief, which is 
a natural and normal reaction to losses that are induced by cancer. Alternatively, the association 
between high QOL and both high positive reframing and high acceptance may also be explained by 
post-traumatic growth after a diagnosis of cancer (i.e., positive changes that are felt after a difficult life 
event) [36]. Our results support the idea that QOL is more strongly associated to the manner in which 
the patient actively copes with the disease (no matter the disease severity) and to the individual 
characteristics prior to the disease than to the severity of the disease or the types of treatment used. 
This study had several limitations, including a small sample size (that did not allow us to 
study the association between QOL and other less prevalent psychiatric disorders), and the use of a 
self-administered questionnaire for personality disorders (that may have over-evaluated the prevalence 
of personality disorders), and the question whether our results are generalizable to other countries or 
cultures. Another limitation of our study was related to the timing of the assessment (end of the initial 
treatment phase): long-term studies could potentially identify different risk factors for lower QOL, 
such as the impact of various types of treatment. Our results are limited to non-metastatic breast cancer 
patients and to patients with similar levels of symptoms (i.e., pain, depression). Finally, we did not 
assessed other important risk factors for lower QOL (e.g., social support) nor other QOL dimensions 
(e.g., social QOL, cognitive functioning or difficulties in ability to work), and we did not use a generic 
QOL questionnaire to compare our population’s QOL scores with the general population.  
This study has several practical implications. Our results highlight the need for early screening 
of all the psychological factors that are associated with lower QOL in breast cancer patients, including 
major depressive disorder, personality disorders, and certain coping strategies (e.g., low positive 
reframing, low acceptance, high self-blame, high behavioral disengagement). Better screening and 
treatment for major depressive disorder is critical given that depressive disorders are highly prevalent 
in breast cancer patients [15,38] and that these disorders are often underdiagnosed and untreated in this 
population, despite the existence of effective psychotherapeutic and pharmacologic treatments [15,39]. 
Such interventions may not only improve QOL in these patients but also improve their tolerance and 
adherence to therapeutic interventions. An early screening program for personality disorders and 
coping styles may detect which patients are at higher risk for lower psychosocial outcomes. 
Subsequently, psychotherapeutic interventions may be proposed based on their personality and coping 
styles (e.g., therapies based on psycho-education with cognitive behavioral interventions such as group 
therapy, stress management techniques, assertiveness training, problem solving or cognitive 
restructuration) [40]. In all cases, therapy must be tailored to the individual person, relationship and 
circumstances that characterize a patient at a particular point in time as they grieve for specific losses 
[41]. 
 
CONCLUSION 
This study demonstrated that in non-metastatic breast cancer, lower physical, emotional and 
global QOL scores were more strongly associated to variables related to the individual’s psychological 
characteristics prior to the disease and to the manner in which this individual copes with the disease 
(e.g., major depressive disorder, personality disorders and use of coping strategies) than to biological 
or physiological variables (e.g., treatment types, cancer severity). Future studies should determine 
whether therapeutic interventions that are based on these psychological factors could improve QOL in 
breast cancer patients.  
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TABLES 
Table 1. Individual characteristics, biological and physiological variables, and symptom 
measures of the study population (n=120). 
 Mean(±SD) 
Number of patients(%) 
Individual characteristics  
   Age at diagnosis (years) 56.4(±10.8) 
   Marital status (single) 37(30.8%) 
   Occupational status (employed) 66(55.4%) 
   Existence of a personality disorder (VKP) 40(33.3%) 
      Cluster A personality disorder 28(23.3%) 
      Cluster B personality disorder 9(7.5%) 
      Cluster C personality disorder 22(18.3%) 
 
Biological and physiological variables 
 
    Initial tumor characteristics (TNM) 
       T (tumor) 
           T=0 
           T=1 
           T=2 
           T=3 
           T=4 
 
 
16(13.3%) 
56(46.7%) 
37(30.8%) 
5(4.2%) 
3(2.5%) 
      N (existence of nodes) 17(14.2%) 
    Hormonal receptors (presence) 98(81.7%) 
  
   Types of treatment received  
     Mastectomy 
     Tumor excision 
     Chemotherapy  
     Radiotherapy 
     Hormone therapy 
44(36.7%)
1
 
90(75%)
1
 
69(57.5%) 
108(90%) 
54(45%) 
 
Symptom measures  
   Major depressive disorder (MINI) 13(10.8%) 
   Pain (total QDSA score) 6.7(±6.2) 
  
Legend: 
1
 Some patients received more than one type of surgery.   
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Table 2. Factors associated with physical, emotional and global QOL in univariate analyses. 
 Physical QOL   Emotional QOL   Global QOL 
Test  p  Test  p  Test  p 
Individual characteristics      
   Age at diagnosis r=-0.13 0.16  r=0.09 0.35  r=0.14 0.14 
   Marital status (single) t=-1.12 0.26  t=0.10 0.92  t=0.50 0.62 
   Occupational status F=1.23 0.29  F=1.56 0.15  F=1.62 0.14 
   Personality disorder (PD)      
      Existence of a PD t=-2.36 <0.001  t=-5.18 <0.001  t=-1.67 0.10 
      Cluster A PD t=-3.30 <0.001  t=-5.93 <0.001  t=-2.37 0.02 
      Cluster B PD t=-3.03 <0.01  t=- 4.99 <0.001  t=-2.70 <0.01 
      Cluster C PD t=-2.41 0.02  t=-4.26 <0.001  t=-2.04 <0.05 
   Coping    
      Active coping r=-0.04 0.70  r=-0.07 0.44  r=-0.08 0.38 
      Planning r=0.08 0.40  r=-0.07 0.48  r=-0.03 0.74 
 Searching for social/emotional 
 support 
r=0.01 0.94  r=-0.19 0.04  r=-0.18 0.05 
      Venting r=-0.03 0.73  r=-0.21 0.02  r=-0.15 0.11 
      Behavioral disengagement r=-0.30 <0.001  r=-0.32 <0.001  r=-0.22 0.02 
      Distraction r=-0.10 0.30  r=-0.13 0.15  r=-0.15 0.11 
      Self-blame r=-0.19 0.04  r=-0.39 <0.001  r=-0.40 <0.001 
      Positive reframing r=0.15 0.09  r=0.20 0.03  r=0.24 <0.01 
      Humor r=-0.02 0.79  r=0.21 0.02  r=0.24 <0.01 
      Denial r=-0.15 0.12  r=-0.40 <0.001  r=-0.17 0.06 
      Acceptance r=0.17 0.06  r=0.53 <0.001  r=0.33 <0.001 
      Religion r=-0.02 0.80  r=-0.17 0.07  r=-0.04 0.69 
      Substance use r=-0.21 0.02  r=-0.11 0.23  r=-0.16 0.08 
      
Biological and physiological variables    
   Initial tumor characteristics    
      T t=-1.50 0.14  t=-0.49 0.63  t=-0.78 0.43 
      N t=-0.89 0.38  t=0.16 0.87  t=-0.53 0.60 
   Presence of hormonal receptors t=-0.35 0.73  t=0.75 0.46  t=-0.23 0.82 
   Types of treatment received    
      Mastectomy t=-1.25 0.21  t=-0.40 0.69  t=-0.03 0.98 
      Tumor excision t=0.79 0.43  t=0.13 0.91  t=0.12 0.91 
      Chemotherapy after surgery t=-0.12 0.91  t=0.34 0.74  t=-1.19 0.24 
      Radiotherapy t=1.46 0.15  t=1.02 0.31  t=0.15 0.88 
      Hormone therapy t=0.30 0.76  t=0.97 0.33  t=2.72 <0.01 
    
Symptom measures    
   Major depressive disorder (MINI) t=-3.22 <0.01  t=-8.81 <0.001  t=-5.20 <0.001 
   Pain (total QDSA score) r=-0.25 <0.01  r=-0.40 <0.001  r=-0.30 <0.001 
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Table 3. Factors associated with physical, emotional and global QOL in multiple linear 
regression. 
 Physical QOL (adjusted R
2
=0.135) 
Estimate±Standard error t-value p 
Intercept 105.14±6.94 15.16 <0.001
 
Age -0.27±0.11 -2.36 0.02 
Initial tumor stage  -2.78±1.40 -1.99 <0.05 
Pain severity -0.33±0.35 -0.93 0.36 
Existence of major depressive disorder -10.62± 3.93 -2.70 <0.01 
Existence of a personality disorder -3.13±2.63 -1.19 0.24 
Use of hormone therapy 2.72±2.37 1.15 0.25 
Coping  
   Behavioral disengagement 
 
-2.85±1.42 
 
-2.00 
 
<0.05 
  
 Emotional QOL (adjusted R
2
=0.487) 
Estimate±Standard error t-value p 
Intercept 80.65±9.37 8.61 <0.001
 
Age 0.18±0.15 1.19 0.23 
Initial tumor stage  -0.69±1.89 -0.36 0.72 
Pain severity -1.12±0.47 -2.36 0.02 
Existence of major depressive disorder -38.19±5.31 -7.20 <0.001 
Existence of a personality disorder -12.70±3.56 -3.57 <0.001 
Use of hormone therapy 3.90±3.20 1.22 0.23 
Coping  
   Acceptance 
   Self-blame 
 
3.93±0.89 
-3.13±1.21 
 
4.40 
-2.58 
 
<0.001
 
<0.01 
  
 Global QOL (adjusted R
2
=0.26) 
Estimate±Standard error t-value p 
Intercept 67.03±9.14 7.34 <0.001
 
Age 0.06±0.15 0.38 0.71 
Initial tumor -0.94±1.84 -0.51 0.61 
Pain severity -0.78±0.46 -1.70 0.09 
Existence of major depressive disorder -24.17±5.17 -4.67 <0.001 
Existence of a personality disorder -0.67±3.47 -0.19 0.85 
Use of hormone therapy 9.49±3.12 3.04 <0.01 
Coping  
   Positive reframing 
   Self-blame 
 
2.29±0.85 
-4.01±1.16 
 
2.71 
-3.46 
 
<0.001 
<0.001 
Legends:  
An estimate of -38.19 for the “existence of major depressive disorder” variable indicates that this 
variable is associated with a significant decrease of 38.19 points in the emotional QOL score, on a 0 to 
100 scale.  
Factors significantly associated with QOL scores are indicated in bold. 
 
 
